Titan Medical (CVE:TMD) said today that it’s looking for a new CEO after the resignation of John Hargrove as it looks to get back on track with the development program for its Sport robot-assisted surgery platform.
Toronto-based Titan said board member John Barker is slated to fill Hargrove’s shoes on an interim basis as he leads the search for a successor. The company also said it named Kerbel Group CFO Martin Bernholtz as chairman.
“Our board and management team are fully committed to advancing the Sport surgical system’s development program in an effective and efficient manner,” Barker said in prepared remarks. “While we are aggressively pursuing plans to advance the program, we have also revised our previously announced executive search effort to focus on recruiting to the company a permanent CEO with a proven leadership and capital markets track record. At the same time, we are examining our cost structure with an eye on focusing resources on the Sport’s development. The board thanks John for his service to Titan Medical during the past 7 years and also appreciates Mr. Bernholtz’ assumption of the chairman’s duties as we execute our plan. We look forward to reporting on our progress as developments merit.” Read more
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.